logo

For the Inventor, By the Inventor

Thousand Oaks, CA, United States of America

Kirin-Amgen, Inc.


USPTO Granted Patents = 23



Forward Citations = 1,570

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Fu-Kuen Lin (5 out of 7 patents)

silverMedal Joel E Tocker (4 out of 12 patents)

bronzeMedal Makoto Kakitani (4 out of 4 patents)

4.  Jacques J Peschon (3 out of 11 patents)

5.  Yuji Okada (3 out of 3 patents)

6.  Rika Ishikawa (3 out of 3 patents)

7.  James F Smothers (2 out of 17 patents)

8.  Dingjiang Liu (2 out of 6 patents)

9.  Holly Zhuohong Huang (2 out of 4 patents)

10.  David Andrew Martin (2 out of 4 patents)

11.  David H Salinger (2 out of 4 patents)

12.  Christopher Boyd Russell (2 out of 4 patents)

13.  Scott Walter Baumgartner (2 out of 4 patents)

14.  Christopher Endres (2 out of 4 patents)

15.  Joan C Egrie (2 out of 7 patents)


23 patents:

1. 10072085 - Method of treating psoriasis using an IL-17 receptor antibody formulation (2018-09-11),
2. 9096673 - IL-17 receptor A antigen binding proteins (2015-08-04),
3. 9073999 - Anti-IL-17 receptor A neutralizing antibodies (2015-07-07),
4. 8883151 - IL-17 receptor antibody formulation (2014-11-11),
5. 8545842 - Polynucleotides encoding IL-17 receptor A antigen binding proteins (2013-10-01),
6. 8435518 - Methods of using IL-17 receptor a antibodies (2013-05-07),
7. 6166183 - Chemically-modified G-CSF (2000-12-25),
8. 616618 - Chemically-modified G-CSF (2000-12-26),
9. 5955422 - Production of erthropoietin (1999-09-21),
10. 5824778 - Chemically-modified G-CSF (1998-10-20),
11. 5798274 - Method for selecting monoclonal antibodies for human G-CSF permitting (1998-08-25),
12. 5621080 - Production of erythropoietin (1997-04-15),
13. 5618698 - Production of erythropoietin (1997-04-08),
14. 5597562 - Oral dosage form of biologically active proteins (1997-01-28),
15. 5552286 - Hybridoma cell lines and their monoclonal antibodies to human (1996-09-03),
Company Overview
Kirin-Amgen, Inc. is a biopharmaceutical company based in Thousand Oaks, California, specializing in the development and manufacturing of innovative therapies. The organization focuses on areas such as oncology, nephrology, and inflammation, leveraging advanced biotechnology to address unmet medical needs. With a commitment to research and development, Kirin-Amgen aims to enhance patient outcomes through cutting-edge treatments and collaborations in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

23 Patents

#17 in Thousand Oaks, CA

#3,419 in California

#14,428 in US

#27,685 in the World

Thousand Oaks, CA (US)
Thousand Oaks, CA, United States of America

Kirin-Amgen, Inc.

Forward Citations = 1,570

32 inventors:

goldMedal Fu-Kuen Lin (5 out of 7 patents)

silverMedal Joel E Tocker (4 out of 12 patents)

bronzeMedal Makoto Kakitani (4 out of 4 patents)

4.  Jacques J Peschon (3 out of 11 patents)

5.  Yuji Okada (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kirin-Amgen, Inc.. Retrieved from https://idiyas.com/company/kirin-amgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…